FDA approves 1st drug for moderate & severe eczema cases

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. The drug is an antibody that's injected just under the skin. It binds to a specific protein to ...
http://ift.tt/2nJgT5v